Full Presentations
Presentation 5 / Gail Martin
Biological Model for the Identification of Malodour Control Agents
Gail Martin
Gail Martin, (GSK) presented a novel biological model to establish clinical relevance of in-vitro data for oral malodour studies - a major step forward in evaluating different therapies.
